Home » Advisory Panel Calls for U.S. FDA Reclassification of TB Devices
Advisory Panel Calls for U.S. FDA Reclassification of TB Devices
August 2, 2011
The FDA’s Microbiology Devices advisory panel has unanimously recommended the U.S. Food and Drug Administration (FDA) consider down-classifying certain diagnostic tests for tuberculosis (TB) infections.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor